Thomas Vercruysse
- Virology top 10%
- HIV Research and Treatment 6
- Neurology top 10%
- Amyotrophic Lateral Sclerosis Research 4
-
- Neurogenetic and Muscular Disorders Research 3
-
- RNA Research and Splicing 4
- Nuclear Structure and Function 3
-
- SARS-CoV-2 and COVID-19 Research 4
- Viral Infections and Outbreaks Research 3
-
- Mosquito-borne diseases and control 3
Thomas Vercruysse
25 papers receiving 636 citations
Peers
Comparison fields: 5 of 76
- Virology 66
- Neurology 112
- Genetics 74
- Molecular Biology 448
- Infectious Diseases 108
Countries citing papers authored by Thomas Vercruysse
This map shows the geographic impact of Thomas Vercruysse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Vercruysse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Vercruysse more than expected).
Fields of papers citing papers by Thomas Vercruysse
This network shows the impact of papers produced by Thomas Vercruysse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Vercruysse. The network helps show where Thomas Vercruysse may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Thomas Vercruysse, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 4 | |
| 2 | 2024 | 2 | |
| 3 | 2023 | 5 | |
| 4 | 2022 | 6 | |
| 5 | 2022 | 4 | |
| 6 | 2022 | 12 | |
| 7 | 2022 | 6 | |
| 8 | 2022 | 5 | |
| 9 | 2022 | 16 | |
| 10 | 2021 | 71 | |
| 11 | 2021 | 10 | |
| 12 | 2019 | 43 | |
| 13 | 2018 | 78 | |
| 14 | 2016 | 53 | |
| 15 | 2015 | 27 | |
| 16 | 2014 | 16 | |
| 17 | 2014 | 25 | |
| 18 | 2013 | 12 | |
| 19 | 2012 | 23 | |
| 20 | 2010 | 57 |
About Thomas Vercruysse
Thomas Vercruysse is a scholar working on Virology, Infectious Diseases and Modeling and Simulation, having authored 25 papers that have together received 643 indexed citations. Recurring topics across this work include HIV Research and Treatment (6 papers), SARS-CoV-2 and COVID-19 Research (4 papers), Amyotrophic Lateral Sclerosis Research (4 papers), RNA Research and Splicing (4 papers), Viral Infections and Outbreaks Research (3 papers), Mosquito-borne diseases and control (3 papers), Neurogenetic and Muscular Disorders Research (3 papers) and Nuclear Structure and Function (3 papers). The work is most often cited by research in Virology (66 citations), Neurology (112 citations) and Genetics (74 citations). Thomas Vercruysse has collaborated with scholars based in Belgium, United States and Germany. Frequent co-authors include Dirk Daelemans, Els Vanstreels, Jasper E. Neggers, Maarten Jacquemyn, Erkan Baloglu, Yosef Landesman, Sharon Shacham, Jan Steyaert, Els Pardon and Marsha Crochiere. Their work appears in journals such as Journal of Biological Chemistry, Nature Communications and The EMBO Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.